Cholera Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cholera Vaccines Market to 2027 - Global Analysis and Forecasts by Product (Dukoral, Shanchol, Vaxchora, Euvichol and Others); End User (Hospitals and Clinics, Research and Academic Laboratories and Others)

Report Code: TIPRE00004078 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Cholera Vaccines is a biological preparation that assists in strengthening the immune system and provides acquired immunity against Cholera. Cholera is a type of infectious disease caused by the bacterium Vibrio Cholera.

MARKET DYNAMICS
The Cholera Vaccine Market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of chronic diseases, lack of proper sanitation & consumption of contaminated food, growth in awareness about cholera preventive care, development of new approaches for new cholera increase and increase in government focus on immunization programs. Nevertheless, risk of adverse effects, high cost associated to the development of vaccine and timelines required for cholera vaccine production may hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Cholera Vaccine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cholera Vaccine Market with detailed market segmentation by Products, End User and geography. The global Cholera Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cholera Vaccine Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Cholera Vaccine Market is segmented on the basis of Product and End User. Based on Product the market is segmented into Dukoral, Shanchol, Vaxchora, Euvichol and Others. Based on End User the market is segmented into Hospitals and Clinics, Research and Academic Laboratories and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cholera Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cholera Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cholera Vaccine Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cholera Vaccine Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Cholera Vaccine Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Cholera Vaccine Market are anticipated to lucrative growth opportunities in the future with the rising demand for Cholera Vaccine Market in the global market. Below mentioned is the list of few companies engaged in the Cholera Vaccine Market.

The report also includes the profiles of key Cholera Vaccine Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Valneva SE
  • PaxVax, Inc.
  • Astellas Pharma, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc (GSK)
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Emergent BioSolutions, Inc.
  • AstraZeneca
  • Mitsubishi Tanabe Pharma Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cholera Vaccine Market - By Product
1.3.2 Cholera Vaccine Market - By End User
1.3.3 Cholera Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CHOLERA VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHOLERA VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHOLERA VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. CHOLERA VACCINE - GLOBAL MARKET OVERVIEW
6.2. CHOLERA VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHOLERA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DUKORAL
7.3.1. Overview
7.3.2. Dukoral Market Forecast and Analysis
7.4. SHANCHOL
7.4.1. Overview
7.4.2. Shanchol Market Forecast and Analysis
7.5. VAXCHORA
7.5.1. Overview
7.5.2. Vaxchora Market Forecast and Analysis
7.6. EUVICHOL AND OTHERS
7.6.1. Overview
7.6.2. Euvichol and Others Market Forecast and Analysis
8. CHOLERA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and Clinics Market Forecast and Analysis
8.4. RESEARCH AND ACADEMIC LABORATORIES AND OTHERS.
8.4.1. Overview
8.4.2. Research and Academic Laboratories and Others. Market Forecast and Analysis
9. CHOLERA VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cholera Vaccine Market Overview
9.1.2 North America Cholera Vaccine Market Forecasts and Analysis
9.1.3 North America Cholera Vaccine Market Forecasts and Analysis - By Product
9.1.4 North America Cholera Vaccine Market Forecasts and Analysis - By End User
9.1.5 North America Cholera Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cholera Vaccine Market
9.1.5.1.1 United States Cholera Vaccine Market by Product
9.1.5.1.2 United States Cholera Vaccine Market by End User
9.1.5.2 Canada Cholera Vaccine Market
9.1.5.2.1 Canada Cholera Vaccine Market by Product
9.1.5.2.2 Canada Cholera Vaccine Market by End User
9.1.5.3 Mexico Cholera Vaccine Market
9.1.5.3.1 Mexico Cholera Vaccine Market by Product
9.1.5.3.2 Mexico Cholera Vaccine Market by End User
9.1.5.4 US Cholera Vaccine Market
9.1.5.4.1 US Cholera Vaccine Market by Product
9.1.5.4.2 US Cholera Vaccine Market by End User
9.2. EUROPE
9.2.1 Europe Cholera Vaccine Market Overview
9.2.2 Europe Cholera Vaccine Market Forecasts and Analysis
9.2.3 Europe Cholera Vaccine Market Forecasts and Analysis - By Product
9.2.4 Europe Cholera Vaccine Market Forecasts and Analysis - By End User
9.2.5 Europe Cholera Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cholera Vaccine Market
9.2.5.1.1 Germany Cholera Vaccine Market by Product
9.2.5.1.2 Germany Cholera Vaccine Market by End User
9.2.5.2 France Cholera Vaccine Market
9.2.5.2.1 France Cholera Vaccine Market by Product
9.2.5.2.2 France Cholera Vaccine Market by End User
9.2.5.3 Italy Cholera Vaccine Market
9.2.5.3.1 Italy Cholera Vaccine Market by Product
9.2.5.3.2 Italy Cholera Vaccine Market by End User
9.2.5.4 Spain Cholera Vaccine Market
9.2.5.4.1 Spain Cholera Vaccine Market by Product
9.2.5.4.2 Spain Cholera Vaccine Market by End User
9.2.5.5 United Kingdom Cholera Vaccine Market
9.2.5.5.1 United Kingdom Cholera Vaccine Market by Product
9.2.5.5.2 United Kingdom Cholera Vaccine Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cholera Vaccine Market Overview
9.3.2 Asia-Pacific Cholera Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Cholera Vaccine Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Cholera Vaccine Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Cholera Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cholera Vaccine Market
9.3.5.1.1 Australia Cholera Vaccine Market by Product
9.3.5.1.2 Australia Cholera Vaccine Market by End User
9.3.5.2 China Cholera Vaccine Market
9.3.5.2.1 China Cholera Vaccine Market by Product
9.3.5.2.2 China Cholera Vaccine Market by End User
9.3.5.3 India Cholera Vaccine Market
9.3.5.3.1 India Cholera Vaccine Market by Product
9.3.5.3.2 India Cholera Vaccine Market by End User
9.3.5.4 Japan Cholera Vaccine Market
9.3.5.4.1 Japan Cholera Vaccine Market by Product
9.3.5.4.2 Japan Cholera Vaccine Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cholera Vaccine Market Overview
9.4.2 Middle East and Africa Cholera Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Cholera Vaccine Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Cholera Vaccine Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Cholera Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cholera Vaccine Market
9.4.5.1.1 South Africa Cholera Vaccine Market by Product
9.4.5.1.2 South Africa Cholera Vaccine Market by End User
9.4.5.2 Saudi Arabia Cholera Vaccine Market
9.4.5.2.1 Saudi Arabia Cholera Vaccine Market by Product
9.4.5.2.2 Saudi Arabia Cholera Vaccine Market by End User
9.4.5.3 U.A.E Cholera Vaccine Market
9.4.5.3.1 U.A.E Cholera Vaccine Market by Product
9.4.5.3.2 U.A.E Cholera Vaccine Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cholera Vaccine Market Overview
9.5.2 South and Central America Cholera Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Cholera Vaccine Market Forecasts and Analysis - By Product
9.5.4 South and Central America Cholera Vaccine Market Forecasts and Analysis - By End User
9.5.5 South and Central America Cholera Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cholera Vaccine Market
9.5.5.1.1 Brazil Cholera Vaccine Market by Product
9.5.5.1.2 Brazil Cholera Vaccine Market by End User
9.5.5.2 Argentina Cholera Vaccine Market
9.5.5.2.1 Argentina Cholera Vaccine Market by Product
9.5.5.2.2 Argentina Cholera Vaccine Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CHOLERA VACCINE MARKET, KEY COMPANY PROFILES
11.1. VALNEVA SE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PAXVAX, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTELLAS PHARMA, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MERCK AND CO., INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. TAKEDA PHARMACEUTICAL CO., LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. EMERGENT BIOSOLUTIONS, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ASTRAZENECA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MITSUBISHI TANABE PHARMA CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Valneva SE
- PaxVax, Inc.
- Astellas Pharma, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc (GSK)
- Pfizer, Inc.
- Takeda Pharmaceutical Co., Ltd.
- Emergent BioSolutions, Inc.
- AstraZeneca
- Mitsubishi Tanabe Pharma Corporation